{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:45:22Z","timestamp":1760121922345},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T00:00:00Z","timestamp":1288915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00392-010-0247-2","type":"journal-article","created":{"date-parts":[[2010,11,4]],"date-time":"2010-11-04T10:05:02Z","timestamp":1288865102000},"page":"327-333","source":"Crossref","is-referenced-by-count":15,"title":["Impact of therapy with statins, beta-blockers and angiotensin-converting enzyme inhibitors on plasma myeloperoxidase in patients with coronary artery disease"],"prefix":"10.1007","volume":"100","author":[{"given":"Gjin","family":"Ndrepepa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siegmund","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Sch\u00f6mig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,5]]},"reference":[{"key":"247_CR1","doi-asserted-by":"crossref","unstructured":"Andreou I, Tousoulis D, Miliou A, Tentolouris C, Zisimos K, Gounari P, Siasos G, Papageorgiou N, Papadimitriou CA, Dimopoulos MA, Stefanadis C (2010) Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study. Atherosclerosis 210:194\u2013198","DOI":"10.1016\/j.atherosclerosis.2009.10.046"},{"key":"247_CR2","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1373\/clinchem.2006.080192","volume":"2007","author":"FS Apple","year":"2007","unstructured":"Apple FS, Pearce LA, Chung A, Ler R, Murakami MM (2007) Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2007:874\u2013881","journal-title":"Clin Chem"},{"key":"247_CR3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jocn.2005.10.016","volume":"14","author":"H Beril Gok","year":"2007","unstructured":"Beril Gok H, Solaroglu I, Okutan O, Cimen B, Kaptanoglu E, Palaoglu S (2007) Metoprolol treatment decreases tissue myeloperoxidase activity after spinal cord injury in rats. J Clin Neurosci 14:138\u2013142","journal-title":"J Clin Neurosci"},{"key":"247_CR4","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa035003","volume":"349","author":"ML Brennan","year":"2003","unstructured":"Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, Nissen SE, Hazen SL (2003) Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349:1595\u20131604","journal-title":"N Engl J Med"},{"key":"247_CR5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJMoa012295","volume":"347","author":"A Buffon","year":"2002","unstructured":"Buffon A, Biasucci LM, Liuzzo G, D\u2019Onofrio G, Crea F, Maseri A (2002) Widespread coronary inflammation in unstable angina. N Engl J Med 347:5\u201312","journal-title":"N Engl J Med"},{"key":"247_CR6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jss.2006.11.021","volume":"141","author":"PA Cowled","year":"2007","unstructured":"Cowled PA, Khanna A, Laws PE, Field JB, Varelias A, Fitridge RA (2007) Statins inhibit neutrophil infiltration in skeletal muscle reperfusion injury. J Surg Res 141:267\u2013276","journal-title":"J Surg Res"},{"key":"247_CR7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijcard.2004.03.017","volume":"100","author":"FM Gusm\u00e3o de","year":"2005","unstructured":"de Gusm\u00e3o FM, Becker C, Carvalho MH, Barros LF (2005) Angiotensin II inhibition during myocardial ischemia-reperfusion in dogs: effects on leukocyte infiltration, nitric oxide synthase isoenzymes activity and left ventricular ejection fraction. Int J Cardiol 100:363\u2013370","journal-title":"Int J Cardiol"},{"key":"247_CR8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.clinbiochem.2009.09.026","volume":"43","author":"KM Eggers","year":"2010","unstructured":"Eggers KM, Dellborg M, Johnston N, Oldgren J, Swahn E, Venge P, Lindahl B (2010) Myeloperoxidase is not useful for the early assessment of patients with chest pain. Clin Biochem 43:240\u2013245","journal-title":"Clin Biochem"},{"key":"247_CR9","doi-asserted-by":"crossref","unstructured":"Fox KM, for the European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease Investigators (2003) Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362:782\u2013788","DOI":"10.1016\/S0140-6736(03)14286-9"},{"key":"247_CR10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0014-2999(00)00641-5","volume":"406","author":"F Gao","year":"2000","unstructured":"Gao F, Chen J, Lopez BL, Christopher TA, Gu J, Lysko P, Ruffolo RR Jr, Ohlstein EH, Ma XL, Yue TL (2000) Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model. Eur J Pharmacol 406:109\u2013116","journal-title":"Eur J Pharmacol"},{"key":"247_CR11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.fjc.0000137160.76616.cc","volume":"44","author":"M Graninger","year":"2004","unstructured":"Graninger M, Reiter R, Drucker C, Minar E, Jilma B (2004) Angiotensin receptor blockade decreases markers of vascular inflammation. J Cardiovasc Pharmacol 44:335\u2013339","journal-title":"J Cardiovasc Pharmacol"},{"key":"247_CR12","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/hrt.2005.061523","volume":"92","author":"J Hippisley-Cox","year":"2006","unstructured":"Hippisley-Cox J, Coupland C (2006) Effect of statins on the mortality of patients with ischaemic heart disease: population based cohort study with nested case-control analysis. Heart 92:752\u2013758","journal-title":"Heart"},{"key":"247_CR13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.bbrc.2005.03.204","volume":"331","author":"AP Kumar","year":"2005","unstructured":"Kumar AP, Reynolds WF (2005) Statins downregulate myeloperoxidase gene expression in macrophages. Biochem Biophys Res Commun 331:442\u2013451","journal-title":"Biochem Biophys Res Commun"},{"key":"247_CR14","first-page":"790","volume":"29","author":"T Macickova","year":"2008","unstructured":"Macickova T, Pecivova J, Nosal R, Lojek A, Pekarova M, Cupanikova D (2008) Inhibition of superoxide generation and myeloperoxidase release by carvedilol after receptor and nonreceptor stimulation of human neutrophils. Neuro Endocrinol Lett 29:790\u2013793","journal-title":"Neuro Endocrinol Lett"},{"key":"247_CR15","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.atherosclerosis.2007.08.011","volume":"197","author":"MC Meuwese","year":"2008","unstructured":"Meuwese MC, Trip MD, van Wissen S, van Miert JN, Kastelein JJ, Stroes ES (2008) Myeloperoxidase levels are not associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia. Atherosclerosis 197:916\u2013921","journal-title":"Atherosclerosis"},{"key":"247_CR16","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.jacc.2007.02.040","volume":"49","author":"TJ Mocatta","year":"2007","unstructured":"Mocatta TJ, Pilbrow AP, Cameron VA, Senthilmohan R, Frampton CM, Richards AM, Winterbourn CC (2007) Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol 49:1993\u20132000","journal-title":"J Am Coll Cardiol"},{"key":"247_CR17","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1373\/clinchem.2006.084194","volume":"53","author":"DA Morrow","year":"2007","unstructured":"Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, Wu AH, Christenson RH, Apple FS, Francis G, Tang W, National Academy of Clinical Biochemistry (2007) National academy of clinical biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 53:552\u2013574","journal-title":"Clin Chem"},{"key":"247_CR18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2362.2007.01908.x","volume":"38","author":"G Ndrepepa","year":"2008","unstructured":"Ndrepepa G, Braun S, Mehilli J, von Beckerath N, Sch\u00f6mig A, Kastrati A (2008) Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes. Eur J Clin Invest 38:90\u201396","journal-title":"Eur J Clin Invest"},{"key":"247_CR19","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.ATV.0000163262.83456.6d","volume":"25","author":"SJ Nicholls","year":"2005","unstructured":"Nicholls SJ, Hazen SL (2005) Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 25:1102\u20131111","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"247_CR20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0735-1097(00)01121-9","volume":"37","author":"T Ohtsuka","year":"2001","unstructured":"Ohtsuka T, Hamada M, Hiasa G, Sasaki O, Suzuki M, Hara Y, Shigematsu Y, Hiwada K (2001) Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy. J Am Coll Cardiol 37:412\u2013417","journal-title":"J Am Coll Cardiol"},{"key":"247_CR21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ahj.2007.10.017","volume":"155","author":"A Stefanescu","year":"2008","unstructured":"Stefanescu A, Braun S, Ndrepepa G, Koppara T, Pavaci H, Mehilli J, Sch\u00f6mig A, Kastrati A (2008) Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease. Am Heart J 155:356\u2013360","journal-title":"Am Heart J"},{"key":"247_CR22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2215\/CJN.01281005","volume":"1","author":"P Stenvinkel","year":"2006","unstructured":"Stenvinkel P, Rodr\u00edguez-Ayala E, Massy ZA, Qureshi AR, Barany P, Fellstr\u00f6m B, Heimburger O, Lindholm B, Alvestrand A (2006) Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients. Clin J Am Soc Nephrol 1:281\u2013287","journal-title":"Clin J Am Soc Nephrol"},{"key":"247_CR23","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0165-6147(02)02077-1","volume":"23","author":"G Weitz-Schmidt","year":"2002","unstructured":"Weitz-Schmidt G (2002) Statins as anti-inflammatory agents. Trends Pharmacol Sci 23:482\u2013487","journal-title":"Trends Pharmacol Sci"},{"key":"247_CR24","volume-title":"Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO Consultation. Part 1 diagnosis and classification of diabetes mellitus","author":"World Health Organization","year":"1999","unstructured":"World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO Consultation. Part 1 diagnosis and classification of diabetes mellitus. World Health Organization, Geneva"},{"key":"247_CR25","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1001\/jama.260.14.2088","volume":"260","author":"S Yusuf","year":"1988","unstructured":"Yusuf S, Wittes J, Friedman L (1988) Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction. JAMA 260:2088\u20132093","journal-title":"JAMA"},{"key":"247_CR26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00392-009-0754-1","volume":"98","author":"U Zeymer","year":"2009","unstructured":"Zeymer U, Parhofer KG, Pittrow D, Binz C, Schwertfeger M, Limbourg T, R\u00f6ther J (2009) Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: results of the prospective German REACH registry cohort. Clin Res Cardiol 98:249\u2013256","journal-title":"Clin Res Cardiol"},{"key":"247_CR27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00392-009-0076-3","volume":"99","author":"Y Zheng","year":"2010","unstructured":"Zheng Y, Ma W, Zeng Y, Liu J, Ye S, Chen S, Lan L, Erbel R, Liu Q (2010) Comparative study of clinical characteristics between Chinese Han and German Caucasian patients with coronary heart disease. Clin Res Cardiol 99:45\u201350","journal-title":"Clin Res Cardiol"},{"key":"247_CR28","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cca.2005.12.040","volume":"368","author":"T Zhou","year":"2006","unstructured":"Zhou T, Zhou SH, Qi SS, Shen XQ, Zeng GF, Zhou HN (2006) The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndrome. Clin Chim Acta 368:168\u2013172","journal-title":"Clin Chim Acta"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-010-0247-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-010-0247-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-010-0247-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T02:31:45Z","timestamp":1559788305000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-010-0247-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,5]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["247"],"URL":"https:\/\/doi.org\/10.1007\/s00392-010-0247-2","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,5]]}}}